The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia

American Journal of Hematology

Volumn 86, Issue 11, 2011, Pages 909-913

  Roca, Manel ^a   Muñiz Diaz, Eduardo ^b   Mora, Jaume ^a   Romero Zayas, Inmaculada ^a   Ramón, Olga ^c   Roig, Inmaculada ^d   Pujol Moix, Núria ^e  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b GENERALITAT DE CATALUNYA   (Spain)

^c Hospital d'Igualada   (Spain)

^d HOSPITAL DE SABADELL   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; THROMBOCYTE IN 111;

ADULT; AGED; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING; CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; HEART; HUMAN; LIVER; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SPLEEN; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTE KINETICS; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CHRONIC DISEASE; FEMALE; HEART; HEMORRHAGE; HUMANS; INDIUM RADIOISOTOPES; LIVER; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PREDNISONE; PROGNOSIS; RADIONUCLIDE IMAGING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPLEEN; SPLENECTOMY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 80054020378     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22147     Document Type: Article

References (35)

1. Chong BH, Ho SJ. Autoimmune thrombocytopenia. Thromb Haemost 2005; 3: 1763-1772.
2. Vianelli N, Galli M, DeVivo A, et al. Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: Long-term results of 402 cases. Haematologica 2005; 90: 72-77.
3. Beardsley DS. ITP in the 21st century (Review). Hematology Am Soc Hematol Educ Program 2006; 2006: 402-407.
4. Ruggeri M, Fortuna S, Rodeghiero F. Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: A critical appraisal from a systematic review of the literature. Haematologica 2008; 93: 98-103.
5. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106: 2244-2251.
6. George JN. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 2006; 4: 1664-1672.
7. Ojima H, Kato T, Araki K, et al. Factors predicting long-term responses to splenectomy in patients with idiopathic thrombocytopenic purpura. World J Surg 2006; 30: 553-559.
8. Houwerzijl EJ, Louwes H, Sluiter WJ, et al. Platelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2008; 87: 975-983.
9. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004; 104: 2623-2634.
10. Burzynski J. New options after first-line therapy for chronic immune thrombocytopenic purpura. Am J Health Syst Pharm 2009; 66(2 Suppl 2): S11-S21.
11. Chouhan JD, Herrington JD. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: Focus on romiplostim and eltrombopag. Pharmacotherapy 2010; 30: 666-683.
12. Vesely SK, Perdue JJ, Rizvi MA, et al. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: A systematic review. Ann Intern Med 2004; 140: 112-120.
13. Lamy T, Moisan A, Dauriac C, et al. Splenectomy in idiopathic thrombocytopenic purpura: Its correlation with the sequestration of autologous indium-111-labeled platelets. J Nucl Med 1993; 34: 182-186.
14. 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: A study of 578 patients with 268 splenectomies. Br J Haematol 1997; 97: 547-550.
15. 111In-labelled platelet scintigraphy to predict the outcome of partial splenic embolization in patients with idiopathic thrombocytopenic purpura. Nucl Med Commun 2000; 21: 441-447.
16. Chen CC, Ho CH, Wu TS, et al. Predictive prognostic factors after splenectomy in patients with idiopathic thrombocytopenic purpura. Haematologica 2001; 86: 663-674.
17. Katkhouda N, Hurwitz MB, Rivera RT, et al. Laparoscopic splenectomy: Outcome and efficacy in 103 consecutive patients. Ann Surg 1998; 228: 568-578.
18. Zheng CX, Zheng D, Chen LH, et al. Laparoscopic splenectomy for immune thrombocytopenic purpura at a teaching institution. Chin Med J 2011; 124: 1175-1180.
19. Wu JM, Lai IR, Yuan RH, Yu SC. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg 2004; 187: 720-723.
20. Berends FJ, Schep N, Cuesta MA, et al. Hematological long-term results of laparoscopic splenectomy for patients with idiopathic thrombocytopenic purpura: A case control study. Surg Endosc 2004; 18: 766-770.
21. Bourgeois E, Caulier MT, Delarozee C, et al. Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: A prospective analysis. Br J Haematol 2003; 120: 1079-1088.
22. Siegel RS, Rae JL, Barth S, et al. Platelet survival and turnover: Important factors in predicting response to splenectomy in immune thrombocytopenic purpura. Am J Hematol 1989; 30: 206-212.
23. Amuasi JH, Ferri P, Grossi A, et al. Quantitative platelet imaging and comparison of four mathematical models for the evaluation of platelet mean life span in patients with chronic immune thrombocytopenia. Haematologica 1991; 76: 104-108.
24. 111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: A report from the United Kingdom ITP Registry. Br J Haematol 2010; 151: 477-487.
25. Peters AM, Saverymuttu SH, Wonke B, et al. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction. Br J Haematol 1984; 57: 637-649.
26. Von dem Borne AE, Helmerhorst FM, Van Leeuwen, EF. Autoimmune thrombocytopenia: Detection of platelet autoantibodies with the suspension immunofluorescence test. Br J Haematol 1980; 45: 319-327.
27. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura (ITP) of adults and children: Report from an International Working Group. Blood 2008; 113: 2386-2393.
28. 111In-Oxina. Rev Esp Med Nucl 1988; 7: 9-13.
29. Thakur ML, Walsh L, Malech HL, Gottschalk A. Indium-111-labeled human platelets: Improved method, efficacy, and evaluation. J Nucl Med 1981; 22: 381-385.
30. International Committee for Standardization in Hematology (ISTH). Recommended method for Indium-111 platelet survival studies. J Nucl Med 1988; 29: 564-566.
31. Rodrigues M, Sinzinger H, Thakur M, Becker W, et al. Labelling of platelets with indium-111 oxine and technetium-99m hexamethylpropylene amine oxime: Suggested methods. International Society of Radiolabelled Blood Elements (ISORBE). Eur J Nucl Med 1999; 26: 1614-1616.
32. Louwes H, Lathori OAZ, Vellenga E, DeWolf JTM. Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura. Am J Med 1999; 106: 430-434.
33. Louwes H, De Wolf JTM, Houwerzijl E, Vellenga E. Evaluation assays measuring platelet kinetics in bone marrow and peripheral blood. An overview. Nucl Med Commun 2002; 23: 581-590.
34. Najean Y, Dufour V, Rain JD, Toubert ME. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy. Br J Haematol 1991; 79: 271-276.
35. Rossi G, Cattaneo C, Motta M, et al. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment. Hematol J 2002;3:148-152.